Literature DB >> 19906018

Long-term vaginal ring pessary use: discontinuation rates and adverse events.

S Sarma1, T Ying, K H Moore.   

Abstract

OBJECTIVE: To evaluate, at a minimum of 6 years, the long-term discontinuation rates and incidence of adverse events associated with vaginal ring pessary use.
DESIGN: Retrospective case identification.
SETTING: Tertiary urogynaecology unit. SAMPLE: All women fitted with either a Portex ring pessary or Introl bladder neck support device during the index period (1992-2002).
METHODS: Retrospective chart review. MAIN OUTCOME MEASURES: Length of use and complications of pessary use, including bleeding, extrusion, malodorous vaginal discharge, constipation and incontinence.
RESULTS: Of the 273 women fitted with a ring pessary, 167 were successfully using it at 4 weeks; subsequently, 93 (56%) experienced complications comprising bleeding, extrusion, severe vaginal discharge, pain and constipation, in that order, although 38 women (23%) had more than one type of complication and most had more than one episode. Only 23 of 167 (14%) continued with pessary use at the study endpoint (November 2008). The median duration of use was 7 years (interquartile range, 6-9 years; range, 2.25-13.9 years). Of those who discontinued, the median duration was 1.4 years (range, 0.1-11 years; interquartile range, 0.5-3.6 years). After cessation, 73 (44%) chose conservative treatment and 50 (30%) chose surgery. Twelve women died during the time frame; nine returned to their GP.
CONCLUSIONS: We were surprised to find a 56% complication rate in pessary users. Our study shows that, over time, the majority of women chose to discontinue using pessaries. Women should be informed of these data when deciding on the management of their pelvic organ prolapse.

Entities:  

Mesh:

Year:  2009        PMID: 19906018     DOI: 10.1111/j.1471-0528.2009.02380.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  35 in total

1.  Effects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora.

Authors:  Kazuaki Yoshimura; Nobuo Morotomi; Kazumasa Fukuda; Toru Hachisuga; Hatsumi Taniguchi
Journal:  Int Urogynecol J       Date:  2015-09-16       Impact factor: 2.894

Review 2.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

3.  Laparoscopic sacrocolpopexy: an observational study of functional and anatomical outcomes.

Authors:  Natalia Price; Alex Slack; Simon R Jackson
Journal:  Int Urogynecol J       Date:  2010-08-26       Impact factor: 2.894

Review 4.  Pelvic organ prolapse: A primer for urologists.

Authors:  Michel Bureau; Kevin V Carlson
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

5.  Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016).

Authors:  K Baeßler; T Aigmüller; S Albrich; C Anthuber; D Finas; T Fink; C Fünfgeld; B Gabriel; U Henscher; F H Hetzer; M Hübner; B Junginger; K Jundt; S Kropshofer; A Kuhn; L Logé; G Nauman; U Peschers; T Pfiffer; O Schwandner; A Strauss; R Tunn; V Viereck
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

6.  Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.

Authors:  Benjamin C Shayo; Gileard G Masenga; Vibeke Rasch
Journal:  Int Urogynecol J       Date:  2018-08-18       Impact factor: 2.894

7.  Symptoms, quality of life, and factors affecting women's treatment decisions regarding pelvic organ prolapse.

Authors:  Symphorosa Shing Chee Chan; Rachel Yau Kar Cheung; Ka Wah Yiu; Lai Loi Lee; Albe Wai Lam Pang; Tony Kwok Hung Chung
Journal:  Int Urogynecol J       Date:  2012-03-08       Impact factor: 2.894

8.  Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years?

Authors:  Alessio Miceli; Manuel Fernández-Sánchez; Juan Polo-Padillo; José-Luis Dueñas-Díez
Journal:  Int Urogynecol J       Date:  2020-02-15       Impact factor: 2.894

9.  Ureterovaginal fistula linked to a retained pessary.

Authors:  Fridman Dmitry; Sleemi Ambereen
Journal:  Int Urogynecol J       Date:  2014-02-14       Impact factor: 2.894

10.  Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.

Authors:  Birte Wolff; Kathryn Williams; Allen Winkler; Lawrence Lind; Dara Shalom
Journal:  Int Urogynecol J       Date:  2016-12-10       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.